- Report
- March 2024
- 146 Pages
Global
From €3900EUR$3,950USD£3,257GBP
- Report
- March 2024
- 132 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 107 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 142 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 140 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 114 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 125 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- February 2024
- 125 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 140 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 146 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 143 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 146 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 140 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 143 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 149 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 143 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 144 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- January 2024
- 145 Pages
Global
From €4197EUR$4,250USD£3,504GBP
- Report
- December 2023
- 140 Pages
Global
From €4394EUR$4,450USD£3,669GBP
- Report
- December 2023
- 140 Pages
Global
From €4394EUR$4,450USD£3,669GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more